Employing a tumourigenic mouse cell line, we have measured the effects of four anti-cancer drugs (methotrexate, vincristine, cis-platinum and adriamycin) upon tumour cell survival as assessed by three independent procedures. The results from two short-term procedures based upon dye exclusion and labeling index determinations were compared with data from the relatively long-term clonogenic or colony-forming assay. The dye exclusion procedure demonstrated the poorest correlation with the clonogenic assay, whereas labeling index measurements exhibited qualitative but not quantitative correspondence with results from the clonogenic assay. These short-term procedures cannot therefore be considered accurate sbustitutes for a clonogenic assay, which remains the method of choice for assessing cytotoxic effects of anti-cancer drugs.
Get full access to this article
View all access options for this article.
References
1.
AlbertsD.S., SalmonS.E., ChenH.S.G., SurwitE.A., SoehnlenB., YoungL., MoonT.E.: In vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy.Lancet, 2: 340–342, 1980.
2.
BergeratJ.P., BarlogieB., GohdeW., JohnstonD.A., DrewinkoB.: In vitro cytokinetic response of human colon cancer cells to cis-dichlorodiammi-neplatinum(II).Cancer Res., 39: 4356–4363, 1979.
3.
BhuyanB.K., LoughmanB.E., FraserT.T., DayD.J.: Comparison of different methods of determining cell viability after exposure to cytotoxic compounds.Exp. Cell Res., 97: 275–280, 1976.
4.
BleyerW.A.: Methotrexate: Clinical pharmacology, current status and therapeutic guidelines.Cancer Treat. Rev., 4: 87–101, 1977.
5.
CostaA., PiazzaR., SanfilippoO., SilvestriniR.: A quantitative test for chemosensitivity of short-term cultures of human lymphomas.Tumori, 63: 237–247, 1977.
6.
DaidoneM.G., SilvestriniR., SanfilippoO.: Clinical relevance of an in vitro antimetabolic assay for monitoring human tumour chemosensitivity. In: Adjuvant Therapy of Cancer. Vol. 3, pp. 25–32. SalmonS.E., JonesS.E. (Eds.), Grune and Stratton, New York, 1981.
7.
DendyP.P., DawsonM.P.A., WarnerD.M.A., HonessD.J.: Quantitative assays of in vitro drug damage. In: Short Term Culture of Human Tumours. pp. 139–149. DendyP. (Ed.), Academic Press, New York, 1976.
8.
DrewinkoB., RoperP.R., BarlogieB.: Patterns of cell survival following treatment with antitumor agents in vitro.Eur. J. Cancer, 15: 93–99, 1979.
9.
DurkinW.J., GhantaV.K., BalchC.M., DavisD.W., HiramotoR.N.: A methodological approach to the prediction of anti-cancer drug effect in humans.Cancer Res., 39: 402–407, 1979.
10.
HillB.T., WhelanR.D.H., RupniakH.T., DennisL.Y., RosholtM.A.: A comparative assessment of the in vitro effects of drugs on cells by means of colony assays or flow microfluorimetry.Cancer Chemother. Pharmacol., 7: 21–26, 1981.
JacobsC., BertinoJ.R., GoffinetD.R., FeeW.E., GoodeR.L.: 24-Hour infusion of cis-platinum in head and neck cancers.Cancer, 42: 2135–2140, 1978.
13.
KrakoffI.H., CvitkovicE., CurrieV., YehS., LaMonteC.: Clinical pharmacologic and therapeutic studies of bleomycin given by continuous infusion.Cancer, 40: 2027–2037, 1977.
14.
LivingstonR.B., TitusG.A., HeilbrunL.K.: In vitro effects on DNA synthesis as a predictor of biological effect from chemotherapy.Cancer Res., 40: 2209–2212, 1980.
15.
RoperP.R., DrewinkoB.: Comparison of in vitro methods to determine drug-induced cell lethality.Cancer Res., 36: 2182–2188, 1976.
16.
RupniakH.T., HillB.T.: The poor cloning ability in agar of human tumour cells from biopsies of primary tumours.Cell Biol. Int. Rep., 4: 479–486, 1980.
17.
SalmonS.E., HamburgerA.W., SoehnlenB., DurieB.G.M., AlbertsD.S., MoonT.E.: Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs.N. Engl. J. Med., 298: 1321–1327, 1978.
18.
SanfilippoO., DaidoneM.G., CostaA., CanettaR., SilvestriniR.: Estimation of differential in vitro sensitivity of non-Hodgkin lymphomas to anticancer drugs.Eur. J. Cancer, 17: 217–226, 1981.
19.
SikicB.I., CollinsJ.M., MimnaughE.G., GramT.E.: Improved therapeutic index of bleomycin when administered by continuous infusion in mice.Cancer Treat. Rep., 62: 2011–2017, 1978.
20.
StrefferC., Van BeuningenD., MollsM., ZamboglouN.: How relevant is the labelling index for cell proliferation? Br. J.Cancer, 41(suppl. 4): 205, 1980.
